Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430016, China
NCT Number: NCT06970561
To study the postoperative recurrence of intraductal papillomas (IDP) treated with ultrasound-guided vacuum-assisted excision (VAE), and to investigate the effect of different lesion characteristics on recurrence.
Looking for future studies?
Notify MeFemale
Observational
Wuhan, Hubei, 430016, China
106 patients with IDP with or without atypical ductal hyperplasia (ADH) treated with ultrasound-guided VAE at Zhongnan Hospital of Wuhan University from January 2020 to August 2024 were selected for the study, and the postoperative conditions of the patients were sorted out and followed up to analyze the characteristics of the lesions and to determine the relevant factors that affected the postoperative recurrence.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients underwent secondary enlarged resection within 1 month after the diagnosis of IDP combined with ADH,
Other names: secondary enlarged resection
Time frame: The cut-off date for follow-up was September 2024
Recurrence was defined as the appearance of a lesion within 2-3 cm of the original surgical area with corresponding clinical manifestations, such as nipple discharge and imaging support, which was later pathologically confirmed as IDP
Wuhan Children's Hospital
Other
Analysis of Factors Associated With Postoperative Recurrence of Intraductal Papilloma of the Breast Treated With Ultrasound-guided Vacuum-assisted Rotary Excision
Acronym: IDP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07588828
Breast Cancer Surgery, Post-operative Seroma Formation
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06973265
Breast Cancer Surgery, Hemic and Lymphatic Diseases
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07077421
Breast Cancer Surgery, Central Sensitization
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06087237
Breast Cancer Surgery, Breast Diseases
Al Mansurah, Egypt
View Trial Details